Published in Neurosci Lett on February 12, 1982
Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease. Acta Neuropathol (1983) 1.91
Dementia in idiopathic Parkinson's disease. A neuropathological study of 32 cases. Acta Neuropathol (1984) 1.23
Orexin/hypocretin modulation of the basal forebrain cholinergic system: Role in attention. Brain Res (2009) 0.98
Is the loss of cerebral cortical choline acetyl transferase activity in Alzheimer's disease due to degeneration of ascending cholinergic nerve cells. J Neurol Neurosurg Psychiatry (1982) 0.92
The substantia innominata and adjacent regions in the human brain: histochemical and biochemical observations. J Anat (1984) 0.92
Dopaminergic neurotransmitter systems in Alzheimer's disease and in Down's syndrome at middle age. J Neurol Neurosurg Psychiatry (1987) 0.81
Reduction in muscarinic receptor binding in limbic areas of Alzheimer brain. J Neurol Neurosurg Psychiatry (1984) 0.78
The nucleus basalis of Meynert in multi-infarct (vascular) dementia. Acta Neuropathol (1986) 0.78
Enhancement of nicotinic receptors alleviates cytotoxicity in neurological disease models. Ther Adv Chronic Dis (2011) 0.78
Alzheimer's disease: recent advances and future prospects. Br Med J (Clin Res Ed) (1983) 0.76
Chronic cerebral ischaemia forms new cholinergic mechanisms of learning and memory. Int J Alzheimers Dis (2010) 0.75
The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry (1968) 18.69
Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J Neurochem (1966) 7.91
Observations on the brains of demented old people. J Neurol Sci (1970) 6.99
CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry (1986) 6.14
The uptake of [3H]GABA by slices of rat cerebral cortex. J Neurochem (1968) 5.05
Diet and risk factors for coronary heart disease in Asians in northwest London. Lancet (1985) 4.83
Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study. Brain (1996) 4.61
Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature (1987) 4.59
Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc Natl Acad Sci U S A (1988) 4.45
Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images. Lancet (2001) 4.28
Observations on the brains of non-demented old people. J Neurol Sci (1969) 4.06
Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet (1999) 4.02
Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects. Arch Neurol (2000) 3.99
The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci U S A (1986) 3.97
Do general practitioners miss dementia in elderly patients? BMJ (1988) 3.95
Role of transmitter uptake mechanisms in synaptic neurotransmission. Br J Pharmacol (1971) 3.82
Prion dementia without characteristic pathology. Lancet (1990) 3.66
Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease. Neurology (2005) 3.58
Fluorescence reaction for amino acids. Anal Chem (1971) 3.55
Extrapyramidal signs in dementia of Alzheimer type. Lancet (1989) 3.52
Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study. Neurology (2009) 3.49
Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease. Ann Neurol (2001) 3.43
Effects of 6-hydroxydopamine on catecholamine containing neurones in the rat brain. J Neurochem (1970) 3.42
A single amino acid change in the cytoplasmic domain allows the influenza virus hemagglutinin to be endocytosed through coated pits. Cell (1988) 3.26
Mental illness and hospital usage in the elderly: a random sample followed up. Compr Psychiatry (1970) 3.25
The role of uptake2 in the extraneuronal metabolism of catecholamines in the isolated rat heart. Br J Pharmacol (1969) 3.25
Evidence for continuous stimulation of interleukin-6 production in Crohn's disease. Gastroenterology (1992) 3.17
Correlation between rates of brain atrophy and cognitive decline in AD. Neurology (1999) 3.07
Inhibition of catecholamine Uptake-2 by steroids in the isolated rat heart. Br J Pharmacol (1970) 3.07
Special problems of the aged and the organization of hospital services. Br Med J (1966) 3.01
The prevalence and causes of dementia in people under the age of 65 years. J Neurol Neurosurg Psychiatry (2003) 2.97
Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature (1998) 2.90
Visualisation and quantification of rates of atrophy in Alzheimer's disease. Lancet (1996) 2.89
Focal white-matter lesions in brain of patients with inflammatory bowel disease. Lancet (1995) 2.81
The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2. Neurology (2005) 2.77
Opiate analgesics inhibit substance P release from rat trigeminal nucleus. Nature (1977) 2.74
Production of listeriolysin by beta-hemolytic strains of Listeria monocytogenes. Infect Immun (1986) 2.66
The retrograde axonal transport of nerve growth factor. Brain Res (1974) 2.60
Isolation and identification of two hemolytic forms of streptolysin-O. Infect Immun (1984) 2.57
Correlation of the highest-energy cosmic rays with nearby extragalactic objects. Science (2007) 2.57
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Progressive cerebral atrophy in MS: a serial study using registered, volumetric MRI. Neurology (2000) 2.47
Release of gamma-aminobutyric acid from inhibitory nerves of lobster. Proc Natl Acad Sci U S A (1966) 2.47
The 1.7 A crystal structure of the regulator of chromosome condensation (RCC1) reveals a seven-bladed propeller. Nature (1998) 2.42
Periodic emission from the gamma-ray binary 1FGL J1018.6-5856. Science (2012) 2.40
Multiple opiate receptor sites on primary afferent fibres. Nature (1980) 2.34
Airway smooth muscle cell proliferation is increased in asthma. Am J Respir Crit Care Med (2001) 2.34
Correlation between scores for dementia and counts of 'senile plaques' in cerebral grey matter of elderly subjects. Nature (1966) 2.23
Frontotemporal lobar degeneration and ubiquitin immunohistochemistry. Neuropathol Appl Neurobiol (2004) 2.19
The possible existence of multiple receptors for substance P. Naunyn Schmiedebergs Arch Pharmacol (1982) 2.18
Amphiphysin heterodimers: potential role in clathrin-mediated endocytosis. Mol Biol Cell (1997) 2.12
Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines. Proc Natl Acad Sci U S A (1996) 2.11
Expression of enzymatically active reverse transcriptase in Escherichia coli. Proc Natl Acad Sci U S A (1985) 2.11
Rates of global and regional cerebral atrophy in AD and frontotemporal dementia. Neurology (2001) 2.09
Subunit structure of paired helical filaments in Alzheimer's disease. J Cell Biol (1985) 2.06
The physiologic disposition and metabolism of norepinephrine in immunosympathectomized animals. J Pharmacol Exp Ther (1966) 2.03
GABA uptake in rat central nervous system: comparison of uptake in slices and homogenates and the effects of some inhibitors. J Neurochem (1971) 2.00
Trans-synaptic regulation of growth and development of adrenergic neurones in a mouse sympathetic ganglion. Brain Res (1971) 1.99
Predisposing locus for Alzheimer's disease on chromosome 21. Lancet (1989) 1.99
Neurofibrillary degeneration and neuronal loss in Alzheimer's disease. Neurobiol Aging (1990) 1.99
7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex. Proc Natl Acad Sci U S A (1988) 1.99
Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur J Pharmacol (1998) 1.96
Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology (2001) 1.95
Release of dopamine from dendrites in rat substantia nigra. Nature (1976) 1.95
Patterns of cortical thinning in the language variants of frontotemporal lobar degeneration. Neurology (2009) 1.95
Reduced uptake of tritiated noradrenaline in tissues of immunosympathectomized animals. Nature (1965) 1.91
Autoradiographic localization of 3 H-GABA in rat retina. Nat New Biol (1972) 1.90
Effects of phenoxybenzamine on the uptake and metabolism of noradrenaline in the rat heart and vas deferens. Br J Pharmacol (1969) 1.90
Selenium, molybdenum, and vanadium in human blood. Arch Environ Health (1968) 1.89
The heritability and genetics of frontotemporal lobar degeneration. Neurology (2009) 1.86
Multiple tachykinin binding sites in peripheral tissues and in brain. Eur J Pharmacol (1986) 1.86
Catecholamine uptake processes. Br Med Bull (1973) 1.83
Uptake and metabolism of gamma-aminobutyric acid by neurones and glial cells. Biochem Pharmacol (1975) 1.83
The inhibition of noradrenaline uptake by drugs. Adv Drug Res (1965) 1.82
Use of catechol O-methyltransferase for the enzyme radiochemical assay of dopamine. J Neurochem (1973) 1.82
Capsaicin-induced depletion of substance P from primary sensory neurones. Brain Res (1978) 1.80
Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death. Proc Natl Acad Sci U S A (1994) 1.79
Dopamine receptors in the brain. Science (1975) 1.79
Neurochemical characteristics of early and late onset types of Alzheimer's disease. Br Med J (Clin Res Ed) (1984) 1.78
DNA intermediates and telomere addition during genome reorganization in Euplotes crassus. Cell (1985) 1.77
Differential expression of immediate early genes in the hippocampus and spinal cord. Neuron (1990) 1.76
Column chromatography of amino acids with fluorescence detection. J Chromatogr (1973) 1.76
Measuring atrophy in Alzheimer disease: a serial MRI study over 6 and 12 months. Neurology (2005) 1.73
Uptake mechanisms for neurotransmitter amines. Biochem Pharmacol (1974) 1.73
Cortical neuronal counts in normal elderly controls and demented patients. Neurobiol Aging (1983) 1.71
Early onset familial Alzheimer's disease: Mutation frequency in 31 families. Neurology (2003) 1.71
Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease. Lancet (1999) 1.68
Sensory physiology, anatomy and immunohistochemistry of Rohon-Beard neurones in embryos of Xenopus laevis. J Physiol (1984) 1.68
Neuropeptide Y distribution in human brain. Nature (1984) 1.66
Inherited prion disease with 144 base pair gene insertion. 2. Clinical and pathological features. Brain (1992) 1.66
Tissue selectivity of substance P alkyl esters: suggesting multiple receptors. Eur J Pharmacol (1983) 1.65
Light pulses that shift rhythms induce gene expression in the suprachiasmatic nucleus. Science (1990) 1.65
Molecular analysis of neurofibrillary degeneration in Alzheimer's disease. An immunohistochemical study. Am J Pathol (1990) 1.64
Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia. Neurology (1982) 1.64